Market News AIOpen the app

BIOA stock news · BioAge Labs

Stories about BioAge Labs (BIOA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BIOA

Follow BioAge Labs (BIOA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BIOA
Free on the App Store and Google Play, or on the web.
  1. Nov 17, 2026, 5:38 PM ET · Market

    BioAge Labs is shifting its focus to eye health and delaying some heart studies while sharing updates on future plans.

    Neutral

    BioAge Labs reported about $350 million in cash, expected to fund operations through 2029, and delayed ASCVD trials pending competitor data. These updates leave its outlook unchanged.